Dr. Jennifer Schwartz, Ph.D. is the Vice President of Clinical Development at Intralytix, Inc. Her primary expertise is in virology, vaccine/drug design and development, and IND-enabling preclinical and clinical development of biologics targeting infectious diseases. She received her B.S. with honors in Biological Sciences from Carnegie Mellon University. Dr. Schwartz earned her M.A., M.Phil. and Ph.D. from Columbia University in Cellular, Molecular and Biophysical Studies at the College of Physicians and Surgeons and performed her post-doctoral training at Yale University School of Medicine.